Common metabolic features of hypertension and type 2 diabetes

被引:18
|
作者
Usui, Isao [1 ]
机构
[1] Dokkyo Med Univ, Dept Endocrinol & Metab, Tochigi, Japan
关键词
Hypertension; Type; 2; diabetes; Obesity; Insulin resistance; Sympathetic nerve; CHRONIC KIDNEY-DISEASE; SKELETAL-MUSCLE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; RISK; VASODILATION; MELLITUS; GLUCOSE; HYPERINSULINEMIA; ACTIVATION;
D O I
10.1038/s41440-023-01233-x
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertension and type 2 diabetes frequently coexist, suggesting that the two diseases have common pathophysiological bases. This review describes the pathophysiological mechanisms of how type 2 diabetes is frequently associated with hypertension. Multiple common factors mediate between both diseases. Factors that induce both type 2 diabetes and hypertension include obesity-induced hyperinsulinemia, activation of the sympathetic nervous system, chronic inflammation, and changes in adipokines. Vascular complications resulting from type 2 diabetes and hypertension include endothelial dysfunction, vasodilation/constriction dysfunction of peripheral vessels and increased peripheral vascular resistance, arteriosclerosis, and chronic kidney disease. While many of these vascular complications are caused by hypertension, they also exacerbate the pathology of hypertension. In addition, insulin resistance in the vasculature blunts insulin-induced vasodilation and blood flow to skeletal muscle, which contributes to impaired glucose uptake to skeletal muscle and glucose intolerance. In obese and insulin-resistant patients, increase in the circulating fluid volume forms the major pathophysiology of elevated blood pressure. On the other hand, in non-obese and/or insulin-deficient patients, especially those in the middle-or later stages of diabetes, peripheral vascular resistance is the major pathophysiology of hypertension.
引用
收藏
页码:1227 / 1233
页数:7
相关论文
共 50 条
  • [41] Small, dense LDL and High-Sensitivity C-Reactive Protein (hs-CRP) in Metabolic Syndrome with Type 2 Diabetes Mellitus
    Nakano, Saburo
    Kuboki, Koji
    Matsumoto, Tomoko
    Nishimura, Chiaki
    Yoshino, Gen
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17 (04) : 410 - 415
  • [42] The factors affecting sleep quality in type 2 diabetes patients
    Tavsanli, Nurgul Gungor
    Sivrikaya, Sibel Karaca
    Menekli, Tugba
    Akyol, Asiye
    KUWAIT MEDICAL JOURNAL, 2019, 51 (03): : 269 - 277
  • [43] Hemoglobin glycation index among adults with type 1 diabetes: Association with double diabetes features
    Ji, Xiao-Lin
    Yin, Min
    Deng, Chao
    Fan, Li
    Xie, Yu-Ting
    Huang, Fan-Su
    Chen, Yan
    Li, Xia
    WORLD JOURNAL OF DIABETES, 2025, 16 (04)
  • [44] Biochemical changes in blood of type 2 diabetes with and without metabolic syndrome and their association with metabolic syndrome components
    Zadhoush, Fouzieh
    Sadeghi, Masoumeh
    Pourfarzam, Morteza
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2015, 20 (08): : 763 - 770
  • [45] A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes
    Efrem, Ion Cristian
    Mota, Maria
    Vladu, Ionela Mihaela
    Mitrea, Adina
    Clenciu, Diana
    Timofticiuc, Diana Cristina Protasiewicz
    Diaconu, Ileana-Diana
    Turcu, Adina
    Crisan, Anda Elena
    Geormaneanu, Cristiana
    Glodeanu, Adina Dorina
    Mahler, Beatrice
    Tudor, Marinela Sinziana
    Amzolini, Anca Maria
    Micu, Simona Elena
    Abu Alhija, Anca Barau
    Mita, Adrian
    Filip, Maria Monalisa
    Fortofoiu, Maria
    DIAGNOSTICS, 2022, 12 (10)
  • [46] KCNQ1 variants associate with hypertension in type 2 diabetes and affect smooth muscle contractility in vitro
    Huang, Kuo-Chin
    Li, Te-Mao
    Liu, Xiang
    Chen, Jin-Hua
    Chien, Wen-Kuei
    Shiao, Yi-Tzone
    Tsang, Hsinyi
    Lin, Ting-Hsu
    Liao, Chiu-Chu
    Huang, Shao-Mei
    Li, Ju-Pi
    Lin, Cheng-Wen
    Lin, Jung-Chun
    Lin, Chih-Chien
    Lai, Chih-Ho
    Cheng, Chi-Fung
    Liang, Wen-Miin
    Hung, Chien-Hui
    Chen, Ching-Chu
    Lin, Ying-Ju
    Tsai, Fuu-Jen
    JOURNAL OF CELLULAR PHYSIOLOGY, 2017, 232 (12) : 3309 - 3316
  • [47] Metabolic control of myofibers: promising therapeutic target for obesity and type 2 diabetes
    Duan, Yehui
    Li, Fengna
    Tan, Bie
    Yao, Kang
    Yin, Yulong
    OBESITY REVIEWS, 2017, 18 (06) : 647 - 659
  • [48] Mechanisms and pharmacotherapy of hypertension associated with type 2 diabetes
    Kamalumpundi, Vijayvardhan
    Shams, Elham
    Tucker, Cally
    Cheng, Linhai
    Peterson, Joshua
    Thangavel, Sanmati
    Ofori, Oloigbe
    Correia, Marcelo
    BIOCHEMICAL PHARMACOLOGY, 2022, 206
  • [49] Type 2 Diabetes and Hypertension A Study on Bidirectional Causality
    Sun, Dianjianyi
    Zhou, Tao
    Heianza, Yoriko
    Li, Xiang
    Fan, Mengyu
    Fonseca, Vivian A.
    Qi, Lu
    CIRCULATION RESEARCH, 2019, 124 (06) : 930 - 937
  • [50] Assessment and management of hypertension in patients with type 2 diabetes
    Thomas, M. C.
    Atkins, R.
    INTERNAL MEDICINE JOURNAL, 2009, 39 (03) : 143 - 149